66.18
1.69%
-1.18
Conmed Corp stock is traded at $66.18, with a volume of 461.03K.
It is down -1.69% in the last 24 hours and down -3.38% over the past month.
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
See More
Previous Close:
$67.36
Open:
$67.57
24h Volume:
461.03K
Relative Volume:
1.12
Market Cap:
$2.08B
Revenue:
$1.29B
Net Income/Loss:
$131.74M
P/E Ratio:
15.72
EPS:
4.21
Net Cash Flow:
$166.13M
1W Performance:
-7.74%
1M Performance:
-3.38%
6M Performance:
-0.34%
1Y Performance:
-20.60%
Conmed Corp Stock (CNMD) Company Profile
Name
Conmed Corp
Sector
Industry
Phone
727-214-2974
Address
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
66.10 | 2.08B | 1.29B | 131.74M | 166.13M | 4.21 |
ABT
Abbott Laboratories
|
128.79 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
BSX
Boston Scientific Corp
|
105.53 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
392.25 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
MDT
Medtronic Plc
|
89.91 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
70.95 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-01-24 | Reiterated | Needham | Buy |
May-22-23 | Initiated | CL King | Buy |
Mar-27-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Mar-21-23 | Initiated | Wells Fargo | Equal Weight |
Oct-12-22 | Initiated | Jefferies | Hold |
Mar-02-22 | Resumed | BofA Securities | Neutral |
Oct-06-21 | Upgrade | Needham | Hold → Buy |
Jul-15-21 | Initiated | UBS | Buy |
May-25-21 | Initiated | Barclays | Overweight |
Nov-26-19 | Downgrade | Needham | Buy → Hold |
Nov-12-19 | Initiated | JP Morgan | Overweight |
Oct-31-19 | Reiterated | Needham | Buy |
Oct-04-19 | Reiterated | Needham | Buy |
Aug-22-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
Apr-18-19 | Initiated | Stifel | Buy |
Apr-16-19 | Reiterated | Needham | Buy |
Jan-23-19 | Reiterated | Needham | Buy |
Oct-16-18 | Initiated | Barclays | Equal Weight |
Aug-07-18 | Reiterated | Needham | Buy |
Aug-02-18 | Reiterated | Needham | Buy |
Apr-26-18 | Reiterated | Needham | Buy |
Feb-01-18 | Reiterated | Needham | Buy |
Jul-27-17 | Reiterated | Needham | Buy |
Apr-27-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Apr-27-17 | Reiterated | Needham | Buy |
Nov-18-16 | Reiterated | Needham | Buy |
Jul-28-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
Apr-28-16 | Reiterated | Needham | Buy |
Oct-22-15 | Reiterated | Northland Capital | Market Perform |
View All
Conmed Corp Stock (CNMD) Latest News
Market Resilience: Conmed Corp (CNMD) Finishes Weak at 67.36, Down -8.97 - The Dwinnex
Wells Fargo & Company Cuts CONMED (NYSE:CNMD) Price Target to $70.00 - MarketBeat
Taking a look at what insiders are doing to gauge the Conmed Corp (CNMD)’s direction - Knox Daily
Behind Conmed Corp’s 52-Week Range: Uncovering Opportunities for Investors - The InvestChronicle
Needham & Company LLC Issues Pessimistic Forecast for CONMED (NYSE:CNMD) Stock Price - Armenian Reporter
Breaking Down Conmed: 4 Analysts Share Their Views - Benzinga
This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Needham cuts CONMED stock target to $91, maintains Buy rating - Investing.com
CONMED Beats Analysts' Q4 Expectations Despite Full-Year Forecast ShortfallNews and Statistics - IndexBox, Inc.
These Analysts Slash Their Forecasts On Conmed After Q4 Results - Benzinga
JPMorgan cuts CONMED stock rating, lowers price target to $70 - Investing.com
Conmed Corp (CNMD) Q4 2024 Earnings Call Highlights: Strong Growth in General Surgery and ... - Yahoo Finance
Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings - MSN
CONMED earnings beat by $0.13, revenue topped estimates - Investing.com
Conmed (CNMD) Surpasses Q4 Earnings and Revenue Estimates - Yahoo Finance
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops By Stock Story - Investing.com Canada
Conmed Q4 Earnings Assessment - Benzinga
Conmed Q4 Earnings Summary & Key Takeaways - Benzinga
Insights into Conmed Q4 Earnings - Benzinga
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock Drops - Yahoo Finance
Earnings Summary: Conmed Q4 - Benzinga
CONMED Earnings Showcase Record Q4 Growth: Surgical Device Giant Posts 26.4% EPS Surge - StockTitan
Global Electrosurgery Generators Market on a Growth Trajectory, Expected to Reach USD 3,359.2 Million by 2035 | Future Market Insights, Inc. - GlobeNewswire Inc.
Stifel maintains CONMED stock Buy rating and $72 target - Investing.com
Blue Trust Inc. Grows Stock Holdings in CONMED Co. (NYSE:CNMD) - Defense World
Oak Family Advisors LLC Sells 7,237 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED (CNMD) to Release Earnings on Wednesday - MarketBeat
Fifth Third Bancorp Lowers Holdings in CONMED Co. (NYSE:CNMD) - MarketBeat
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now - MSN
YieldBoost CONMED From 1.1% To 12.4% Using Options - Nasdaq
Conmed (CNMD) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Nisa Investment Advisors LLC Sells 1,529 Shares of CONMED Co. (NYSE:CNMD) - Defense World
Orthopedic Biomaterial Market Generated Opportunities, - openPR
CONMED Co. (NYSE:CNMD) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
CONMED Co. (NYSE:CNMD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
AMI Asset Management Corp Has $1.40 Million Stock Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Biopsy Devices Market Global Report and Company Analysis 2025-2033 Featuring Cardinal Health, Hologic, Danaher, Becton, Dickinson and Co, Boston Scientific, Medtronic, Olympus, and CONMED - Yahoo Finance
Avity Investment Management Inc. Makes New Investment in CONMED Co. (NYSE:CNMD) - MarketBeat
CONMED Corporation Furnishes Investor Presentation at J.P. Morgan Healthcare Conference**On January 13, 2025, CONMED Corporation (NYSE: CNMD) disclosed in an 8-K filing that it would be presenting an investor presentation at the J.P. Morgan Healt - Defense World
Tealwood Asset Management Inc. Takes Position in CONMED Co. (NYSE:CNMD) - MarketBeat
Conmed Highlights Growth Strategy at Healthcare Conference - TipRanks
Contrasting CONMED (NYSE:CNMD) & electroCore (NASDAQ:ECOR) - Defense World
Nordea Investment Management AB Acquires 17,633 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
Should Value Investors Buy CONMED (CNMD) Stock? - Yahoo Finance
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025 - Business Wire
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference - Business Wire
What Does CONMED Corporation's (NYSE:CNMD) Share Price Indicate? - Yahoo Finance
CONMED Co. (NYSE:CNMD) Shares Sold by Franklin Resources Inc. - MarketBeat
Franklin Resources Inc. Sells 3,983,156 Shares of CONMED Co. (NYSE:CNMD) - Defense World
Brokerages Set CONMED Co. (NYSE:CNMD) Price Target at $79.80 - MarketBeat
Principal Financial Group Inc. Acquires 25,047 Shares of CONMED Co. (NYSE:CNMD) - MarketBeat
Conmed Corp Stock (CNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):